Related Experiment Video
Updated: Feb 11, 2026

A Modified Trier Social Stress Test for Vulnerable Mexican American Adolescents
Published on: July 10, 2017
ER stress in prostate cancer: A therapeutically exploitable vulnerability?
Christopher Logothetis1, Ana Aparicio2, Timothy C Thompson2
1Department of Genitourinary Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA. clogothe@mdanderson.org.
Abstract:
Cooperative oncogenic effects resulting from the loss of PTEN and overexpression of MYC overcome the deleterious effects of endoplasmic reticulum stress not only to promote the growth of aggressive prostate cancer but also to expose a new therapy target for this disease (Nguyen et al, this issue).
Insights
Loss of PTEN and MYC overexpression cooperate to drive aggressive prostate cancer growth, overcoming endoplasmic reticulum stress and revealing a novel therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Prostate cancer progression is complex, involving genetic alterations.
- Endoplasmic reticulum (ER) stress can impede tumor growth.
- The roles of PTEN loss and MYC overexpression in aggressive prostate cancer require further elucidation.
Purpose of the Study:
- To investigate the cooperative oncogenic effects of PTEN loss and MYC overexpression in prostate cancer.
- To determine if these genetic alterations can overcome ER stress-induced growth inhibition.
- To identify potential new therapeutic targets in aggressive prostate cancer.
Main Methods:
- Utilizing genetically engineered mouse models.
- Employing molecular biology techniques to assess gene expression and protein levels.
- Analyzing tumor growth and response to stress conditions.
Main Results:
- Cooperative loss of PTEN and MYC overexpression promotes aggressive prostate cancer growth.
- These genetic changes effectively overcome the inhibitory effects of ER stress.
- The interplay between PTEN, MYC, and ER stress highlights a new therapeutic vulnerability.
Conclusions:
- The combined effect of PTEN loss and MYC overexpression is a potent driver of aggressive prostate cancer.
- Targeting the pathways affected by these alterations may offer a novel therapeutic strategy.
- Understanding the ER stress response in the context of these oncogenes is crucial for developing effective treatments.
Related Concept Videos
Therapeutic Index
Responses to Salt Stress
Responses to Heat and Cold Stress
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...
Stress
General State of Stress
Specifically, consider a tetrahedral element where one face, labeled XYZ, is perpendicular to the line OA, and the remaining faces align with the coordinate axes with point O as the origin. At any point, such as point O, the stress tensor can be used to determine the stress...

